Nathalie Compagnone
Amministratore Delegato presso Innovative Concepts in Drug Development SAS
Profilo
Nathalie Compagnone is the founder and currently holds the position of Chief Executive & Scientific Officer at Innovative Concepts in Drug Development SAS, which she founded in 2007.
She previously worked as Head-Laboratory at The University of California, San Francisco and as Principal at Trophos SA. Dr. Compagnone holds an MBA degree from Rutgers State University of New Jersey and an undergraduate degree from Université de Franche-Comté.
Posizioni attive di Nathalie Compagnone
| Società | Posizione | Inizio |
|---|---|---|
Innovative Concepts in Drug Development SAS
 Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Amministratore Delegato | 01/01/2007 |
Precedenti posizioni note di Nathalie Compagnone
| Società | Posizione | Fine |
|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Formazione di Nathalie Compagnone
| Rutgers State University of New Jersey | Masters Business Admin |
| Université de Franche-Comté | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Innovative Concepts in Drug Development SAS
Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Health Technology |
- Borsa valori
- Insiders
- Nathalie Compagnone
